Active substances
Hyaluronic acid + Hyaluronic acid cross linked
- SFDA 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| HYADENT BARRIER GEL | 2,16 mg,mg | Gel for injection · Dental use | 2 Cartridge | SAR 329.40 | Generic · Prescription | Bioscience GmbH | Valid |
| HYAcorp MLF1 - HYAcorp MLF2 | 2,20 mg,mg | Gel · Intradermal use | 1 Pre-filled syringe | SAR 966.66 | Generic · Prescription | Bioscience GmbH | Valid |
| Hyacorp Face | 2,20 mg,mg | Gel · Intradermal use | 2 Pre-filled syringe | SAR 934.44 | Generic · Prescription | Bioscience GmbH | Valid |
| Hyacorp Face | 2,20 mg/ml,mg/ml | Gel · Intradermal use | 1 Pre-filled syringe | SAR 233.60 | Generic · Prescription | Bioscience GmbH | Valid |
| Hyacorp Lips | 2,16 mg,mg | Gel · Intradermal use | 1 Pre-filled syringe | SAR 254.75 | Generic · Prescription | Bioscience GmbH | Valid |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.